Asclemed USA Inc. Recalls

1 recall on record in the United States

drugs: 1
drugs Class II
2026-06-10

Asclemed USA Inc. recalls Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabel

CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.

View recall details →